Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
EXELIXIS, INC. | Director | Common Stock | 1.28M | $26.6M | $20.76 | May 31, 2024 | Direct |
BIOGEN INC. | Director | Common Stock | 17.4K | $4.31M | $248.00 | Jun 15, 2022 | Stelios Holdings, LLC |
BIOGEN INC. | Director | Common Stock | 10.8K | $2.69M | $248.00 | Jun 15, 2022 | Esperanza Holdings, LLC |
BIOGEN INC. | Director | Common Stock | 10.1K | $2.5M | $248.00 | Jun 15, 2022 | Direct |
Regulus Therapeutics Inc. | Director | Common Stock | 978K | $1.57M | $1.60 | Mar 14, 2024 | Direct |
Regulus Therapeutics Inc. | Director | Stock Option (Right to Buy) | 60K | May 20, 2024 | Direct | ||
EXELIXIS, INC. | Director | Option (right to buy) | 0 | May 20, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
EXEL | EXELIXIS, INC. | May 31, 2024 | 1 | $0 | 4 | Jun 4, 2024 | Director |
EXEL | EXELIXIS, INC. | May 20, 2024 | 3 | -$11.5K | 4 | May 22, 2024 | Director |
RGLS | Regulus Therapeutics Inc. | May 20, 2024 | 1 | $0 | 4 | May 21, 2024 | Director |
RGLS | Regulus Therapeutics Inc. | May 16, 2024 | 1 | $0 | 4 | May 17, 2024 | Director |
RGLS | Regulus Therapeutics Inc. | Mar 14, 2024 | 1 | $400K | 4 | Mar 15, 2024 | Director |
RGLS | Regulus Therapeutics Inc. | Aug 10, 2023 | 1 | $0 | 4 | Aug 14, 2023 | Director |
RGLS | Regulus Therapeutics Inc. | Jun 13, 2023 | 1 | $0 | 4 | Jun 13, 2023 | Director |
EXEL | EXELIXIS, INC. | Jun 1, 2023 | 1 | $0 | 4 | Jun 2, 2023 | Director |
RGLS | Regulus Therapeutics Inc. | Apr 13, 2023 | 1 | $200K | 4 | Apr 14, 2023 | Director |
BIIB | BIOGEN INC. | Jun 15, 2022 | 1 | $0 | 4 | Jun 17, 2022 | Director |
RGLS | Regulus Therapeutics Inc. | Jun 9, 2022 | 1 | $0 | 4 | Jun 10, 2022 | Director |
EXEL | EXELIXIS, INC. | May 26, 2022 | 1 | $0 | 4 | May 27, 2022 | Director |
EXEL | EXELIXIS, INC. | Feb 22, 2022 | 1 | -$1.65M | 4 | Feb 24, 2022 | Director |
RGLS | Regulus Therapeutics Inc. | Nov 30, 2021 | 1 | $800K | 4 | Dec 1, 2021 | Director |
BIIB | BIOGEN INC. | Jul 1, 2021 | 1 | $0 | 4 | Jul 2, 2021 | Director |
RGLS | Regulus Therapeutics Inc. | Jun 14, 2021 | 1 | $0 | 4 | Jun 15, 2021 | Director |
EXEL | EXELIXIS, INC. | May 27, 2021 | 1 | $0 | 4 | May 28, 2021 | Director |
EXEL | EXELIXIS, INC. | May 11, 2021 | 9 | -$6.39K | 4 | May 13, 2021 | Director |